AVGO enters the final stretch before its June 3 earnings with a modest pullback from recent highs, a cost-to-borrow spike worth watching, and options traders showing just a touch more caution than last week.
The price action is the clearest starting point. Broadcom fell 2.3% on Tuesday to $411.07, extending a 2% weekly decline that pulls the stock roughly 3% off the highs it touched after this month's wave of analyst upgrades. That follows a 29% rally from April lows — so the pullback looks like consolidation rather than a reversal, and the one-month return remains positive at just over 1%. The more interesting question is what positioning data says about market expectations into June 3.
Options are nudging toward mild caution, though not aggressively so. The put/call ratio ticked up to 1.16 on Tuesday — slightly above its 20-day average of 1.14 and sitting at roughly 0.7 standard deviations above that mean. That's a gentle lean toward downside protection, not a panic hedge. It is, however, a meaningful shift from the picture painted in last week's note, when the PCR had dropped to near its 52-week low. The year's range runs from 0.89 to 1.23, and the current reading is comfortably in the middle — cautious but far from extreme. The more pointed move came in cost to borrow, which jumped to 0.58% on Tuesday from 0.26% the session before — a near-doubling in a single day, and the highest level in the 30-day window. It remains cheap in absolute terms, but the direction is notable. Availability is essentially unconstrained, with shares available to borrow vastly exceeding short interest, so the CTB move doesn't point to a lending squeeze. Short interest itself is minimal at 1.16% of free float — up about 3% on the week but still well within the noise range for a stock of this size.
The Street remains firmly constructive heading into earnings, with UBS the latest to move. Timothy Arcuri raised his target to $490 from $475 on Monday, maintaining a Buy — the second bellwether move in a week after Wells Fargo's $545 target and TD Cowen's $500 raise last week. Those upgrades pushed the consensus mean to $477.59, implying around 16% upside from the current price. Every recent action has been a raise or reiterate; no firm has cut or downgraded. The bull case centres on AI custom accelerator demand, virtualization software from the VMware integration, and cash flow durability. Bears point to tariff exposure, China export risk, and a valuation that still prices in a great deal — the P/E stands near 29x with EV/EBITDA around 23x, both compressing modestly over 30 days but still premium. The ORTEX quality score is strong at 84.7 and the 90-day EPS momentum score ranks in the 71st percentile, offering some fundamental support to the Street's optimism.
Peer performance this week was sharply divergent, which adds context to AVGO's mild slip. ALAB surged 13% on Tuesday and is up nearly 20% on the week. MRVL gained 4% on Tuesday and 7% on the week. CRDO also bounced 8% Tuesday despite a rough week overall. NVDA was roughly flat across both timeframes. Against that backdrop, Broadcom's 2% weekly decline looks like modest sector underperformance — the AI infrastructure theme is clearly still drawing buyers, just more selectively this week.
Insider activity from the spring remains a background note rather than a signal. The most significant trades were clustered in early April, when division presidents sold roughly $15 million in aggregate near the $345–$370 range. Chairman Henry Samueli sold around $66 million in late March closer to $320. Those disposals have aged into routine territory now that the stock has moved well above those levels. No purchases have appeared.
The countdown to June 3 is now the organising frame. The last three earnings prints produced a day-one move of -1.1%, then -3.3%, then +6.0% — no consistent pattern. With options only modestly defensive and short interest negligible, the setup heading in is neither squeezed nor heavily hedged; the result itself will do the work.
See the live data behind this article on ORTEX.
Open AVGO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
